Anti-Infective Agents Market Size, Share & Trends Analysis Report By Type (Antibacterial, Antiviral, Antifungal & Antiparasitic), By Route Of Administration (Oral, Parenteral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

Anti-Infective Agents Market Size, Share & Trends Analysis Report By Type (Antibacterial, Antiviral, Antifungal & Antiparasitic), By Route Of Administration (Oral, Parenteral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030


Reusable Water Bottle Market Growth & Trends

The global reusable water bottle market size is expected to reach USD 12.60 billion by 2030, registering a CAGR of 4.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. Government regulations and the anti-plastic movement are encouraging consumers to switch to disposable water bottles and prompting manufacturers to develop environmentally-friendly products.

Moreover, the extensive use of disposable water bottles in sports and public places is discouraged by various campaigns in order to create awareness among people, likely promoting the market growth. Some governments have taken initiatives for the same, for instance, in February 2019, UNICEF and the Ministry of Education Maldives decided to provide reusable water bottles to all the first graders in the Maldives.

Additionally, increasing environmental awareness among consumers is likely to remain the fundamental driver for the growth of the reusable water bottle market. Due to this, majority of the leading players in the market have adopted new strategies, which are commonly driven by the need to improve the consumer experience.

During the COVID-19 pandemic, consumers have refrained from physical shopping and largely opted for online purchases. This scenario has driven the manufacturers, to distribute their products via online channels, promoting the growth of reusable water bottles through the online distribution channel. For instance, this trend has encouraged many new entrants and existing companies such as 24Bottles, Friendly Cup, and United Bottles to drive up sales using online traction.

In terms of material type, the plastic segment is expected to register the fastest CAGR from the year 2022 to 2030. With sustainability becoming a major issue owing to the surge in plastic waste generated by single-use plastic water bottles, several countries like India, Canada, the U.K., and France, have banned single-use plastics and are promoting the reuse and refilling of bottles, likely propelling segment growth.

Reusable Water Bottle Market Report Highlights
  • Plastic reusable water bottle sales accounted for a revenue share of over 35% in 2024. This is attributed to the low cost of manufacturing by producers.
  • Supermarkets/hypermarket-driven sales accounted for a revenue share of over 39% in 2024, driven by their widespread accessibility, extensive product variety, and competitive pricing.
  • The North America reusable water bottle market accounted for a share of 27.58% of the global market revenue in 2024. Urbanization and changes in lifestyle are the factors that are contributing to market growth across the world.
  • The Asia Pacific reusable water bottle market is expected to grow at a CAGR of 5.1% from 2025 to 2030. In Asian countries like India, though most of the PET bottles are or claim to be 100% recyclable, inadequate recycling facilities pose a threat to the environment.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.1.1 Market Definitions
1.1.2 Estimates And Forecast Timeline
1.2 Objectives
1.2.1 Objective - 1
1.2.2 Objective - 2
1.2.3 Objective - 3
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database
1.4.2 Gvr’s Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.5 Information Or Data Analysis
1.5.1 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Epidemiology-Based Market Analysis
1.7.1.1 Approach 1: Epidemiology-Based Approach
1.7.1.2 Approach 2: Commodity Flow Approach
1.7.1.3 Approach 2: Revenue share analysis Using Bottom-up Approach
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Research Assumptions
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 By Type and Route of Administration Snapshot
2.3 By Distribution Channel Segment Snapshot
2.4 Competitive Landscape Snapshot
Chapter 3 Anti-infective Agents Market Variables, Trends, and Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing Incidence Of Targeted Diseases
3.2.1.2 Growing Investments On R&D Activities Of Anti-Infective Drugs
3.2.1.3 Rise In Initiatives For The Awareness Of Infectious Diseases
3.2.2 Market Restraint Analysis
3.2.2.1 Emergence of Resistance to Anti-infective Drugs and Adverse Effects Associated with them
3.3 Anti-infective Agents Market Analysis Tools
3.3.1 Porter’s Five Forces Analysis
3.3.2 Pestle Analysis
Chapter 4 Anti-infective Agents Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)
4.1 Anti-infective Agents Market: Type Movement Analysis
4.2 Anti-infective Agents Market Estimates & Forecast, By Type (USD Million)
4.2.1 Antibacterials
4.2.1.1 Cephalosporins
4.2.1.2 Penicillin
4.2.1.3 Fluoroquinolones
4.2.1.4 Macrolides
4.2.1.5 Carbapenem
4.2.1.6 Others
4.2.2 Antivirals
4.2.3 Antifungals
4.2.3.1 Azoles
4.2.3.2 Echinocandins
4.2.3.3 Polyenes
4.2.3.4 Others
Chapter 5 Anti-infective Agents Market - Segment Analysis, by Route of Administration, 2018 - 2030 (USD Million)
5.1 Anti-infective Agents Market: Route of Administration Movement Analysis
5.2 Anti-infective Agents Market Estimates & Forecast, By Route of Administration (USD Million)
5.2.1 Topical
5.2.2 Oral
5.2.3 Parental
5.2.4 Others
Chapter 6 Anti-infective Agents Market - Segment Analysis, by Distribution Channel, 2018 - 2030 (USD Million)
6.1 Anti-infective Agents Market: Distribution Channel Movement Analysis
6.2 Anti-infective Agents Market Estimates & Forecast, By Distribution Channel (USD Million)
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Others
Chapter 7 Anti-infective Agents Market: Regional Estimates and Trend Analysis by Type, Route of Administration, and Distribution Channel
7.1 Anti-infective Agents Market: Regional Outlook
7.2 North America
7.2.1 North America Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 Key Country Dynamics
7.2.2.2 U.S. Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2.3 Competitive/Market Scenario
7.2.2.4 Regulatory Framework
7.2.2.5 Reimbursement Scenario
7.2.3 Canada
7.2.3.1 Key Country Dynamics
7.2.3.2 Canada Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3.3 Competitive/Market Scenario
7.2.3.4 Regulatory Framework
7.2.3.5 Reimbursement Scenario
7.2.4 Mexico
7.2.4.1 Key Country Dynamics
7.2.4.2 Mexico Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4.3 Competitive/Market Scenario
7.2.4.4 Regulatory Framework
7.2.4.5 Reimbursement Scenario
7.3 Europe
7.3.1 Europe Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.2 UK
7.3.2.1 Key Country Dynamics
7.3.2.2 UK Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2.3 Competitive/Market Scenario
7.3.2.4 Regulatory Framework
7.3.2.5 Reimbursement Scenario
7.3.3 Germany
7.3.3.1 Key Country Dynamics
7.3.3.2 Germany Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3.3 Competitive/Market Scenario
7.3.3.4 Regulatory Framework
7.3.3.5 Reimbursement Scenario
7.3.4 France
7.3.4.1 Key Country Dynamics
7.3.4.2 France Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4.3 Competitive/Market Scenario
7.3.4.4 Regulatory Framework
7.3.4.5 Reimbursement Scenario
7.3.5 Italy
7.3.5.1 Key Country Dynamics
7.3.5.2 Italy Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5.3 Competitive/Market Scenario
7.3.5.4 Regulatory Framework
7.3.5.5 Reimbursement Scenario
7.3.6 Spain
7.3.6.1 Key Country Dynamics
7.3.6.2 Spain Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6.3 Competitive/Market Scenario
7.3.6.4 Regulatory Framework
7.3.6.5 Reimbursement Scenario
7.3.7 Denmark
7.3.7.1 Key Country Dynamics
7.3.7.2 Denmark Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7.3 Competitive/Market Scenario
7.3.7.4 Regulatory Framework
7.3.7.5 Reimbursement Scenario
7.3.8 Sweden
7.3.8.1 Key Country Dynamics
7.3.8.2 Sweden Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8.3 Competitive/Market Scenario
7.3.8.4 Regulatory Framework
7.3.8.5 Reimbursement Scenario
7.3.9 Norway
7.3.9.1 Key Country Dynamics
7.3.9.2 Norway Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9.3 Competitive/Market Scenario
7.3.9.4 Regulatory Framework
7.3.9.5 Reimbursement Scenario
7.3.10 Rest Of Europe Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.2 Japan
7.4.2.1 Key Country Dynamics
7.4.2.2 Japan Anti-infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.2.3 Competitive/Market Scenario
7.4.2.4 Regulatory Framework
7.4.2.5 Reimbursement Scenario
7.4.3 China
7.4.3.1 Key Country Dynamics
7.4.3.2 China Anti-infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.3.3 Competitive/Market Scenario
7.4.3.4 Regulatory Framework
7.4.3.5 Reimbursement Scenario
7.4.4 India
7.4.4.1 Key Country Dynamics
7.4.4.2 India Anti-infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.4.3 Competitive/Market Scenario
7.4.4.4 Regulatory Framework
7.4.4.5 Reimbursement Scenario
7.4.5 Australia
7.4.5.1 Key Country Dynamics
7.4.5.2 Australia Anti-infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.5.3 Competitive/Market Scenario
7.4.5.4 Regulatory Framework
7.4.5.5 Reimbursement Scenario
7.4.6 Thailand
7.4.6.1 Key Country Dynamics
7.4.6.2 Thailand Anti-infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.6.3 Competitive/Market Scenario
7.4.6.4 Regulatory Framework
7.4.6.5 Reimbursement Scenario
7.4.7 South Korea
7.4.7.1 Key Country Dynamics
7.4.7.2 South Korea Anti-infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.7.3 Competitive/Market Scenario
7.4.7.4 Regulatory Framework
7.4.7.5 Reimbursement Scenario
7.4.8 Rest Of Asia Pacific Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5 Latin America
7.5.1 Latin America Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Key Country Dynamics
7.5.2.2 Brazil Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2.3 Competitive/Market Scenario
7.5.2.4 Regulatory Framework
7.5.2.5 Reimbursement Scenario
7.5.3 Argentina
7.5.3.1 Key Country Dynamics
7.5.3.2 Argentina Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3.3 Competitive/Market Scenario
7.5.3.4 Regulatory Framework
7.5.3.5 Reimbursement Scenario
7.5.4 Rest Of Latin America Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6 MEA
7.6.1 MEA Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 Key Country Dynamics
7.6.2.2 South Africa Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2.3 Competitive/Market Scenario
7.6.2.4 Regulatory Framework
7.6.2.5 Reimbursement Scenario
7.6.3 Saudi Arabia
7.6.3.1 Key Country Dynamics
7.6.3.2 Saudi Arabia Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3.3 Competitive/Market Scenario
7.6.3.4 Regulatory Framework
7.6.3.5 Reimbursement Scenario
7.6.4 UAE
7.6.4.1 Key Country Dynamics
7.6.4.2 UAE Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4.3 Competitive/Market Scenario
7.6.4.4 Regulatory Framework
7.6.4.5 Reimbursement Scenario
7.6.5 Kuwait
7.6.5.1 Key Country Dynamics
7.6.5.2 Kuwait Anti-infective Agents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5.3 Competitive/Market Scenario
7.6.5.4 Regulatory Framework
7.6.5.5 Reimbursement Scenario
7.6.6 Rest Of MEA Anti-Infective Agents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 8 Competitive Landscape
8.1 Participant Categorization
8.2 Participant's Overview
8.3 Financial Performance
8.4 Product Benchmarking
8.5 Company Market Positioning Analysis, 2024
8.6 Key Company Profiles
8.6.1. Pfizer Inc.
8.6.1.1. Company overview
8.6.1.2. Financial performance
8.6.1.3. Product benchmarking
8.6.1.4. Strategic initiatives
8.6.2. Bayer AG
8.6.2.1. Company overview
8.6.2.2. Financial performance
8.6.2.3. Product benchmarking
8.6.2.4. Strategic initiatives
8.6.3. AbbVie
8.6.3.1. Company overview
8.6.3.2. Financial performance
8.6.3.3. Product benchmarking
8.6.3.4. Strategic initiatives
8.6.4. Gilead Sciences, Inc.
8.6.4.1. Company overview
8.6.4.2. Financial performance
8.6.4.3. Product benchmarking
8.6.4.4. Strategic initiatives
8.6.5. Bristol-Myers Squibb
8.6.5.1. Company overview
8.6.5.2. Financial performance
8.6.5.3. Product benchmarking
8.6.5.4. Strategic initiatives
8.6.6. Merck & Co., Inc.
8.6.6.1. Company overview
8.6.6.2. Financial performance
8.6.6.3. Product benchmarking
8.6.6.4. Strategic initiatives
8.6.7. Sandoz International GmbH
8.6.7.1. Company overview
8.6.7.2. Financial performance
8.6.7.3. Product benchmarking
8.6.7.4. Strategic initiatives
8.6.8. B. Braun SE
8.6.8.1. Company overview
8.6.8.2. Financial performance
8.6.8.3. Product benchmarking
8.6.8.4. Strategic initiatives
8.6.9. Xellia Pharmaceuticals
8.6.9.1. Company overview
8.6.9.2. Financial performance
8.6.9.3. Product benchmarking
8.6.9.4. Strategic initiatives
8.6.10. Mankind Pharma
8.6.10.1. Company overview
8.6.10.2. Financial performance
8.6.10.3. Product benchmarking
8.6.10.4. Strategic initiatives
8.6.11. AstraZeneca
8.6.11.1. Company overview
8.6.11.2. Financial performance
8.6.11.3. Product benchmarking
8.6.11.4. Strategic initiatives
8.6.12. Boehringer Ingelheim International GmbH
8.6.12.1. Company overview
8.6.12.2. Financial performance
8.6.12.3. Product benchmarking
8.6.12.4. Strategic initiatives
Chapter 9 Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings